Respiratory syncytial virus vaccine oral - VaxartAlternative Names: RSV tablet vaccine - Vaxart; VXA-RSV-f oral vaccine
Latest Information Update: 04 Jul 2016
At a glance
- Originator Vaxart
- Class Respiratory syncytial virus vaccines
- Mechanism of Action Immunostimulants; Toll-like receptor 3 agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Respiratory syncytial virus infections